332 related articles for article (PubMed ID: 9884313)
1. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
Pichette V; Geadah D; du Souich P
Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
[TBL] [Abstract][Full Text] [Related]
2. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
Castañeda-Hernández G; Vergés J; Pichette V; Héroux L; Caillé G; du Souich P
Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
[TBL] [Abstract][Full Text] [Related]
3. The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.
Pichette V; Geadah D; du Souich P
Br J Pharmacol; 1996 Nov; 119(5):885-90. PubMed ID: 8922736
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
[TBL] [Abstract][Full Text] [Related]
5. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
[TBL] [Abstract][Full Text] [Related]
6. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
[TBL] [Abstract][Full Text] [Related]
7. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and dynamics of furosemide in the newborn piglet.
Miceli JJ; Kramer PA; Chapron DJ; Rosenkrantz TS; Raye JR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1126-32. PubMed ID: 2359020
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Knauf H; Mutschler E
Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
[TBL] [Abstract][Full Text] [Related]
10. [Diuretic agents in urine extracts: clearance studies, tubular glucose absorption and blood pressure].
Heuer LJ; Studt J
Arzneimittelforschung; 1979; 29(3):549-51. PubMed ID: 582743
[TBL] [Abstract][Full Text] [Related]
11. Renal nerves do not modulate the renal and endocrine responses to furosemide in conscious lambs.
Smith FG; Strack AM; de Wildt SN
Can J Physiol Pharmacol; 1996 May; 74(5):614-20. PubMed ID: 8884028
[TBL] [Abstract][Full Text] [Related]
12. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
[TBL] [Abstract][Full Text] [Related]
13. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
Green TP; Mirkin BL
J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
[TBL] [Abstract][Full Text] [Related]
14. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
Ha HA; Lee SH; Kim SH; Kim ON; Lee MG
Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):109-28. PubMed ID: 8865375
[TBL] [Abstract][Full Text] [Related]
15. Determinants of furosemide delivery to its site of action.
Sjöström PA; Kron BG; Odlind BG
Clin Nephrol; 1995 Jan; 43 Suppl 1():S38-41. PubMed ID: 7781204
[TBL] [Abstract][Full Text] [Related]
16. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
Nowicki S; Opezzo JA; Levin G; Gonzalez D; Elias MM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1348-54. PubMed ID: 7562507
[TBL] [Abstract][Full Text] [Related]
17. Effect of furosemide on renal excretion of oxypurinol and purine bases.
Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
[TBL] [Abstract][Full Text] [Related]
18. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
19. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
20. Furosemide dynamics in conscious rabbits: modulation by angiotensin II.
Homsy W; Marleau S; du Souich P
Cardiovasc Drugs Ther; 1995 Apr; 9(2):311-7. PubMed ID: 7662598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
